$26.94
0.391.47%
Last update: May 14, 3:24 PM
Genmab AS Earnings Estimates
GMABNASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, during market hours
Genmab Earnings Estimates, EPS & Revenue | NASDAQ:GMAB
Genmab (GMAB) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $0.31 and quarterly revenue of $5.75B.
In the most recent quarter (Q1), Genmab reported EPS of $0.08, missing estimates of $0.17 by 0.51%. Revenue came in at $896.00M, missing the estimate of $4.71B by 0.81%.
Genmab has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Genmab has averaged an EPS surprise of 0.58% and a revenue surprise of 0.77%.
Earnings Date
Aug 6
EPS Estimate
$0.310
Quarterly Revenue Estimate
$5.75B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.90B
Genmab Earnings History
Analyze the earnings history of Genmab using advanced sorting and filters.
Loading calendar...
Genmab (GMAB) Earnings Per Share
The chart below shows Genmab's reported EPS compared to analyst estimates over recent quarters.
Genmab (GMAB) Revenue
The chart below shows Genmab's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab (GMAB) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Genmab (NASDAQ:GMAB)?
The Actual EPS was $0.08, which missed the estimate of $0.17.
What were Genmab’s (NASDAQ:GMAB) revenues?
The Actual Revenue was $896.00M, which missed the estimate of $4.71B.
